Sørensen M, Kowalski A, Nielsen H. "一种达拉非尼杂质20的合成方法" [P]. European Patent, EP 3921076 A1, 2025-07-28.
Johansson L, Mueller T C, Kowalski A. "Method for the Synthesis of Dabrafenib Impurity 20" [P]. European Patent, EP 3011501 A1, 2019-01-17.
发明人马晓峰,唐晓军,杨光. "A Process for Preparing High-Purity Dabrafenib Impurity 20" [P]. 中国发明专利, 专利号 CN 116195120 B, 授权公告日 2020-02-28.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 达拉非尼杂质20 in Pharmaceutical Formulations". Anal. Methods, 2012, 2340, 7262-7266.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达拉非尼杂质20 as an Impurity". J. Pharm. Biomed. Anal., 2010, 893, (2), 1937-1963.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Dabrafenib Impurity 20 Using HRMS and NMR". J. Sep. Sci., 2010, 909, (2), 2684-2687.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 达拉非尼杂质20 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2016, 837, 4800-4822.